Selected article for: "mesenchymal stem cell and tissue regeneration"
Author: Sadeghian Chaleshtori, Sirous; Mokhber Dezfouli, Mohammad Reza; Jabbari Fakhr, Massoumeh
Title: Mesenchymal stem/stromal cells: the therapeutic effects in animal models of acute pulmonary diseases
  • Cord-id: mmq9j8wz
  • Document date: 2020_5_11
    • ID: mmq9j8wz
    Snippet: The pulmonary diseases are one of the most important causes of death in the world. The successful therapies in the field of lung diseases are very limited and the medical treatments available are ineffective in many of the lung diseases. Many studies have evaluated the new therapies in the acute pulmonary diseases, and the transplantation of mesenchymal stem/stromal cells (MSCs), which is a branch of cell therapy, has a special place among the new medical techniques. The MSCs are present through
    Document: The pulmonary diseases are one of the most important causes of death in the world. The successful therapies in the field of lung diseases are very limited and the medical treatments available are ineffective in many of the lung diseases. Many studies have evaluated the new therapies in the acute pulmonary diseases, and the transplantation of mesenchymal stem/stromal cells (MSCs), which is a branch of cell therapy, has a special place among the new medical techniques. The MSCs are present throughout the body and are thought to play a role in tissue regeneration and inflammation control. In the event of injury, the local MSCs traverse the shortest possible distance from the tissue or blood vessels to reach the affected site. But, there are few undifferentiated cells in the tissues. The exogenous MSCs are used to immunity modify or regenerative treatments in preclinical models of acute pulmonary diseases. Several studies have shown the positive effects of MSCs replacement in the acute lung disorders. The effection mechanism of the MSCs include the differentiation ability and the secretion of paracrine agents such as the anti-inflammatory mediators. Many studies suggest that this treatment method is safe and is probably to be widely used in future clinical trials. This review will describe the therapeutic effects of the MSCs in the experimental models of the acute pulmonary diseases for use as a method of treatment in clinical trials in future.

    Search related documents:
    Co phrase search for related documents
    • abnormal lung and acute disease: 1, 2
    • abnormal lung and acute lung inflammation: 1
    • abnormal lung and acute lung injury: 1, 2, 3, 4
    • abnormal lung and acute lung injury repair: 1
    • abnormal lung and acute phase: 1
    • abnormal lung and local systemic: 1, 2
    • abnormal lung and lps ards induce model: 1
    • abnormal lung and lps induce: 1, 2
    • abnormal lung and lung airway: 1, 2, 3, 4, 5, 6
    • abnormal lung and lung damage: 1, 2, 3, 4, 5, 6, 7
    • abnormal lung and lung damage repair: 1
    • abnormal lung and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • abnormal lung and lung function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27
    • abnormal lung and lung function improve: 1
    • abnormal lung and lung inflammation: 1, 2, 3
    • abnormal lung and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • abnormal lung and lung parenchyma: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • abnormal lung and lung tissue: 1, 2, 3, 4, 5
    • abnormal lung and lymph node: 1